TTP negatively regulates cell growth in several cancer cell types by inhibiting the stability of many mRNA implicated in cell cycle (c-Myc, cyclin D1), inflammation (TNFα, COX-2), apoptosis (Bcl-2, Mcl-1), and angiogenesis (VEGF) [7,13,31,32]. This evidence concerns the gene CCND1 and cancer.